Organogenesis signed market sale agreement for up to $75M Class A Common Stock
Organogenesis, Inc. partnered with BTIG and Citizens JMP Securities to issue up to $75M worth of Class A common stock through at-the-market sales, subject to shareholder approval and market availability restrictions.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day